Head to Head Contrast: H. Lundbeck A/S- (HLUYY) and Gilla (GLLA)

Share on StockTwits

H. Lundbeck A/S- (OTCMKTS:HLUYY) and Gilla (OTCMKTS:GLLA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for H. Lundbeck A/S- and Gilla, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
H. Lundbeck A/S- 2 1 1 0 1.75
Gilla 0 0 0 0 N/A

Profitability

This table compares H. Lundbeck A/S- and Gilla’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
H. Lundbeck A/S- 20.91% 38.08% 22.72%
Gilla -137.19% N/A -130.57%

Dividends

H. Lundbeck A/S- pays an annual dividend of $0.95 per share and has a dividend yield of 2.1%. Gilla does not pay a dividend. H. Lundbeck A/S- pays out 37.8% of its earnings in the form of a dividend.

Institutional & Insider Ownership

0.1% of H. Lundbeck A/S- shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares H. Lundbeck A/S- and Gilla’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
H. Lundbeck A/S- $2.62 billion 3.38 $398.58 million $2.51 17.73
Gilla $4.60 million 1.14 -$6.64 million N/A N/A

H. Lundbeck A/S- has higher revenue and earnings than Gilla.

Summary

H. Lundbeck A/S- beats Gilla on 9 of the 10 factors compared between the two stocks.

About H. Lundbeck A/S-

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Denmark and internationally. Its products include Abilify Maintena, Brintellix/Trintellix, Cipralex/Lexapro, Northera, Onfi, Rexulti, Sabril, and Xenazine. The company offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington's disease, and symptomatic neurogenic orthostatic hypotension. H. Lundbeck A/S sells its products to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.

About Gilla

Gilla Inc. engages in the manufacture, marketing, and distribution of generic and premium branded e-liquid used in vaporizers, electronic cigarettes, and other vaping hardware and accessories in Europe, Canada, and the United States. The company offers its products under the brand names of Spectrum Concentrates, Coil Glaze, Craft Vapes, Siren, The Drip Factory, Shake It, Surf Sauce, Ohana, Moshi, Crisp, Just Fruit, Vinto Vape, Vapor's Dozen, Enriched Vapor, and Crown E-liquid. Gilla Inc. sells its products through market channels, including vape shops, retail and wholesale distributors, convenience stores, and e-commerce Websites. The company is headquartered in Daytona Beach, Florida.

Receive News & Ratings for H. Lundbeck A/S- Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S- and related companies with MarketBeat.com's FREE daily email newsletter.